Taiho Pharmaceutical Announces Start of Global Phase III Clinical Trial in Metastatic Colorectal Cancer with Novel Antitumor Age... (l. In Japanese: Taiho Pharmaceutica...)

HOME >> MEDICINE >> TECHNOLOGY

Taiho Pharmaceutical Announces Start of Global Phase III Clinical Trial in Metastatic Colorectal Cancer with Novel Antitumor Agent TAS-102

Date:5/31/2012

l.
In Japanese: http://www.taiho.co.jp/corporation/news/2011/20110722.html
In English: http://www.taiho.co.jp/english/news/20110722.html

About Taiho Pharmaceutical Co., Ltd.

Taiho Pharmaceutical, a subsidiary of Otsuka Holdings Co., Ltd., is an R&D-driven specialty pharma focusing on the three fields of oncology, allergies and immunology, and urology. Its corporate philosophy takes the form of a pledge: "We strive to improve human health and contribute to the enrichment of society." In the field of oncology in particular, Taiho Pharmaceutical is known as a leading company in Japan and around the world for developing evidence-based medicines for the treatment of cancer. In areas other than oncology as well, the company creates quality products that effectively treat medical conditions and can help improve people's quality of life. Always putting customers first, Taiho Pharmaceutical also aims to offer over-the-counter medicinal products that support people's efforts to lead fulfilling and rewarding lives. The company is headquartered in Tokyo and its President is Masayuki Kobayashi.

For more information about Taiho Pharmaceutical, please visit http://www.taiho.co.jp/english/

About Otsuka Holdings Co., Ltd.

The Otsuka Group is a diversified healthcare group operating globally under the corporate philosophy "Otsuka-people creating new products for better health worldwide". The Otsuka Group has business operations in 24 countries and regions around the world, and its consolidated sales for FY2011 are 1,154.6 billion Japanese yen. For more information, please visit the company's website at www.otsuka.com/en/.

Contact:
Mitsutoshi Utatsu
Public Relations Dept.
Taiho Pharmaceutical Co., L
'/>"/>

SOURCE Taiho Pharmaceutical Co., Ltd.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3
Related medicine technology :

1. Taiho Pharmaceutical Announces Results of Randomized Phase II Clinical Trial with Novel Antitumor Agent TAS-102
2. Lexicon Pharmaceuticals to present at the Jefferies 2012 Global Healthcare Conference
3. Hybrid Fuels, Inc. Announces Name Change to Nouveau Life Pharmaceuticals, Inc.
4. Clean Room Environmental Best Practices for Medical Device & Pharmaceutical Manufacturers are Focus of Boston Seminar on June 6
5. AcelRx Pharmaceuticals Announces Pricing of a $10.0 Million PIPE Financing
6. Isis Pharmaceuticals to Present at the Goldman Sachs 33rd Annual Global Healthcare Conference
7. Auxilium Pharmaceuticals, Inc. to Present at the Goldman Sachs Global Healthcare Conference 2012
8. Vanda Pharmaceuticals to Present at the Jefferies 2012 Global Healthcare Conference
9. Cannabis Science Gets Set to Release "Phytiva" Its Newest Brand of Over-the-Counter Skin and Nutraceutical Product Lines Through its Newest Venture Phytiva Pharmaceuticals Inc.
10. Oramed Pharmaceuticals Granted Core Technology Patent in New Zealand
11. Syndax Pharmaceuticals to Present Updated Overall Survival Data With Entinostat in Metastatic Breast Cancer at ASCO

Post Your Comments:

(Date:6/19/2013)... 2013 Echo Therapeutics, Inc. (Nasdaq: ... ® CGM System as a non-invasive, wireless ... of a previously announced underwritten public offering of ... full exercise of the over-allotment option to purchase ... the public of $2.70 per share. The total gross ...

(Date:6/19/2013)... 19, 2013 Eli Lilly and Company (NYSE: ... two illegal scams, purportedly using the name of the ... actively targeting the public through postal mail solicitations and ... connection to any foreign lottery organizations and do not ... job-seeking victims of the scam. The activities described in ...

(Date:6/19/2013)... 19, 2013 Reportlinker.com ... research report is available in its ... Investments and M&A Deals and Trends ... http://www.reportlinker.com/p0925641/Partnerships-Licensing-Investments-and-MA-Deals-and-Trends-for-May-2013-in-Pharmaceuticals.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Investment_Banking ... and Trends for May 2013 in ...

[0] Echo Therapeutics Announces Closing of Public Offering of Common Stock And Full Exercise of Over-Allotment Option by the Underwriter [0] Lilly Issues Alert for Illegal Scams Involving Fraudulent Checks and Online Job Requests [0] Partnerships, Licensing, Investments and M&A Deals and Trends for May 2013 in Pharmaceuticals

... , April 28 Xlumena, a privately ... announced it has received clearance from the US Food ... Device. The NAVIX™ Device is an advanced endoscopy system, ... and dilation balloons and two guidewire ports, designed to ...

... The biopharma mega-mergers that grabbed headlines last year - Roche ... in the critical post-integration period and the acquiring companies are finding out ... for final verdicts, but clearly one M&A issue that continues to create ... , , ...

Cached Medicine Technology:FDA Clears Xlumena's NAVIX(TM) Access Device 2 Bio-Pharma Industry Experts Deliver M&A Value Through Integration Excellence 2 Bio-Pharma Industry Experts Deliver M&A Value Through Integration Excellence 3

FDA Clears Xlumena's NAVIX(TM) Access Device Bio-Pharma Industry Experts Deliver M&A Value Through Integration Excellence

(Date:6/19/2013)... York, NY (PRWEB) June 19, 2013 Citi Bike ... There’s no way for Dr. David Perna to know for sure ... service, but he’s happy that they’ll have the option. In ... healthier lives—especially if it might also make it more convenient for ... Dr. Perna is the Director of Complimentary Alternative Medicine at Back ...

(Date:6/19/2013)... June 19, 2013 According to a June ... Weekend Sunburn,” it is not uncommon for a person to ... months. A person is likely to forget to reapply sunscreen ... is both dry and itchy. When this occurs, it is ... goo.gl/gDyjP). , “Most people do not realize that milk contains ...

(Date:6/19/2013)... surgery have had a significant impact on survival ... injuries, including burns. Patients who survive the ... greatest risk from infections particularly the overwhelming, ... from inflammation-induced multiorgan failure. Now, a device ... measures the movement of key immune cells may ...

(Date:6/19/2013)... is believed to be the largest follow-up record of ... a movement disorder that can cause crippling muscle ... success rates and lasting benefits. , Michele Tagliati, MD, ... Medical Center,s Department of Neurology, and Ron L. Alterman, ... Israel Deaconess Medical Center in Boston, published the study ...

(Date:6/19/2013)... of three important studies have been published in the ... the Congress of Neurological Surgeons . The ... , a part of Wolters Kluwer Health . ... artificial neural networks (ANNs) may improve the ability to ... study in the June Neurosurgery supports increased ...

Breaking Medicine News(10 mins):Health News:New York City's Back and Body Medical Welcomes Citi Bike to Midtown Manhattan 2 Health News:New York City's Back and Body Medical Welcomes Citi Bike to Midtown Manhattan 3 Health News:Skin Care – How to treat Sunburn 2 Health News:Restoring appropriate movement to immune cells may save seriously burned patients 2 Health News:Restoring appropriate movement to immune cells may save seriously burned patients 3 Health News:Long-term study reports deep brain stimulation effective for most common hereditary dystonia 2 Health News:Neurosurgery publishes findings of 3 important studies in June issue 2 Health News:Neurosurgery publishes findings of 3 important studies in June issue 3

[0] New York City's Back and Body Medical Welcomes Citi Bike to Midtown Manhattan [0] Skin Care – How to treat Sunburn [0] Restoring appropriate movement to immune cells may save seriously burned patients [0] Long-term study reports deep brain stimulation effective for most common hereditary dystonia [0] Neurosurgery publishes findings of 3 important studies in June issue

... LAKE FOREST, Ill. and MINNEAPOLIS , ... Fitness Corporation (NYSE AMEX: FIT ) today announced that ... the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act in ... http://www.newscom.com/cgi-bin/prnh/20090122/CG61641LOGO ) , On January 21, 2010 , ...

... WASHINGTON , Feb. 5 In response ... today, the American Veterinary Medical Association (AVMA) is reaffirming its ... help maintain and improve the health of U.S. livestock. , ... creating a new strategy for animal disease traceability. This comes ...

... ... San Francisco,s famed PIER 39 docks, was successfully rescued, rehabilitated and released back to the ... assembled at Rodeo Beach in the Marin Headlands, Sausalito, CA to watch as "Abagnale" made ... ...

... focus of new laws, online testing and Super Bowl plug ... improve treatment of concussions in youth sports are making headway ... in scholastic sports will get big play Sunday at Super ... can help athletic trainers and doctors determine when it,s safe ...

... LOS ANGELES , Feb. 5 Food 4 ... to support children,s hospitals in the communities its stores serve in ... Chicago area. In addition, the supermarket chain,s Foods Co ... California . , Customers and team members can support their ...

... Finding may further understanding of common diseases, researchers say , ... map of areas of the human genome that control which ... a finding that may advance understanding of the genetic ... the human genome is uncharted territory -- entire stretches of ...

Cached Medicine News:Health News:Trustmark and HealthFitness Announce Early Termination of Hart-Scott-Rodino Waiting Period 2 Health News:Trustmark and HealthFitness Announce Early Termination of Hart-Scott-Rodino Waiting Period 3 Health News:Trustmark and HealthFitness Announce Early Termination of Hart-Scott-Rodino Waiting Period 4 Health News:AVMA Calls for Stronger Animal Disease Traceability System 2 Health News:Entangled in Fishing Line then Rescued by The Marine Mammal Center - a Sea Lion Goes Back to the Ocean 2 Health News:Entangled in Fishing Line then Rescued by The Marine Mammal Center - a Sea Lion Goes Back to the Ocean 3 Health News:Entangled in Fishing Line then Rescued by The Marine Mammal Center - a Sea Lion Goes Back to the Ocean 4 Health News:Concussion Awareness for Young Athletes Gets Big Play 2 Health News:Food 4 Less Charitable Campaign to Benefit Children's Hospitals 2

Trustmark and HealthFitness Announce Early Termination of Hart-Scott-Rodino Waiting Period AVMA Calls for Stronger Animal Disease Traceability System Entangled in Fishing Line then Rescued by The Marine Mammal Center - a Sea Lion Goes Back to the Ocean Concussion Awareness for Young Athletes Gets Big Play Food 4 Less Charitable Campaign to Benefit Children's Hospitals Genome Mapped for Type 2 Diabetes

The latex-free, PVC-free Antibacterial Hydro Personal catheter combines two remarkable innovations into one exclusive catheter that delivers an antibacterial agent while providing the virtually frict...

... It's easy on delicate urethral ... and hydrophilic coating provide nearly ... gel. It's easy to maintain ... catheter with its own sterile ...

... Rochester Medical's line ... the intermittent catheters you ... All four product configurations ... and antibacterial hydro - ...

Medicine Products:

Antibacterial Hydro Personal Catheter-Female Antibacterial Hydro Personal Catheter Closed System-Kit Hydrophilic Personal Catheter-Male Personal Catheter-Female